This application is for the continuation of the existing Partnership beWveen Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB Comprehensive Cancer Center (UABCCC). The Partnership, located in the heart ofthe Southeast, a region with a large, historically underserved African American population, has goals of attaining excellence in research focused on the basis of cancer health disparities and on reducing the cancer burden. All three institutions, w/hich are assisting underserved communities, possess unique strengths that supplement each other. The primary objectives are to maintain progress in establishing productive cancer research programs at MSM and TU and to persist in developing a pipeline of prospective minority investigators at TU. The Partnership has three Cores (Administrative, Planning &Evaluation, and Developmental). Within the Developmental Core, there are four Research Programs and two Shared Resources (Bioethics and Biostatistics). With the Research Programs, the Partnership will continue: 1) to tap the pool of talented students and faculty at MSM and TU through the Research Training and Career Development (RTCD) Program, linking them to established Investigators and to the research infrastructure at the UABCCC;2) to promote a Developmental Research (DR) Program, which provides funding for research projects;3) to encourage graduate and undergraduate students across various scientific disciplines to pursue careers in the biosciences through our Cancer Education Program and to provide a pipeline into our RTCD and DR Programs;and 4) to promote cancer awareness and healthy lifestyles among our underserved populations and increase minority participation in therapeutic clinical trails our established Community Outreach Program. The Bioethics Shared Resource promotes and ensures adherence to bioethical principles and addresses ethical considerations in relationships among our institutions and between institutions and communities. The Biostatistics Shared Resource maintains statistical support to all programs. The Partnership will continue to demonstrate its enhanced capability to conduct research on cancer health disparities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118623-09
Application #
8734326
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y (O1))
Program Officer
Ogunbiyi, Peter
Project Start
2005-09-28
Project End
2016-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
9
Fiscal Year
2014
Total Cost
$1,121,683
Indirect Cost
$489,478
Name
Tuskegee University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
128214178
City
Tuskegee
State
AL
Country
United States
Zip Code
36088
Chen, Ina; Mathews-Greiner, Lesley; Li, Dandan et al. (2017) Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med 15:92
Piyathilake, Chandrika J; Badiga, Suguna; Borak, Samuel G et al. (2017) A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 9:413-420
Afolabi, Michael O S; Sodeke, Stephen O (2017) Reconciling Competence and Consent in Opioid-Dependence Research: The Value of Vulnerability Rhetoric. Am J Bioeth 17:48-50
Ahmed, Md Shakir Uddin; Salam, Ahmad Bin; Yates, Clayton et al. (2017) Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer. Int J Nanomedicine 12:6973-6984
Williams, Samuel K; Braxton, Joanne M; Gosdin, Melissa et al. (2017) Evidence-Based Care for the Elderly: Uses of ""the Grandmother Principle"". J Health Care Poor Underserved 28:7
Gao, Song; Wang, Yicun; Wang, Meng et al. (2017) MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. Oncotarget 8:41451-41464
Zhang, Guangxin; Zhang, Wei; Li, Bingjin et al. (2017) MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer. Breast Cancer Res 19:73
Afolabi, Michael O S; Sodeke, Stephen O (2017) A Multifaceted Approach Is Needed to Respond to the Plight of Bioethicists in Accessing Literature. Am J Bioeth 17:37-39
Zhang, Yifan; Li, Bingjin; Zhang, Xingyi et al. (2017) CD24 is a genetic modifier for risk and progression of prostate cancer. Mol Carcinog 56:641-650
Sodeke, Stephen O; Wilson, Wylin D (2017) Integrative Bioethics is a Bridge-Builder Worth Considering to Get Desired Results. Am J Bioeth 17:30-32

Showing the most recent 10 out of 129 publications